This decline correlates with slower wound healing, thinner skin, reduced collagen production, and many other hallmarks of aging
BPC-157 came off the FDA Category 2 list effective April 23, 2026, and is one of the seven peptides under PCAC review for 503A compounding eligibility in July 2026
A pending CagriSema NDA and reported retatrutide Phase 3 toplines are not approvals
Great purity Verified 99.2% purity in our lab
The findings were published in Biochemical and Biophysical Research Communications under the title describing a tripeptide in human serum that prolongs survival of normal liver cells and stimulates growth in neoplastic liver tissue, marking the formal entry of GHK-Cu into the scientific literature
Please dont give up on yourself, healing takes a long time and never give up when you feel let down by the world